A systematic review 1 including 24 placebo-controlled RCTs with a total of 1087 children aged 0 - 18 years was abstracted in DARE.
The overall weighted relative improvement in mean (RIM) total symptom score (15 trials) was 50% (95% CI 49% to 51%). Overall weighted RIM cough score (16 trials) was 24% (95% CI 23% to 25%). Overall weighted RIM wheeze score was 36% (95% CI 35% to 37%). Overall weighted relative decrease in mean beta-agonist use (14 trials) was 37% (95% CI 36% to 38%). Overall weighted absolute improvement in PEF rate was 11% predicted value (95% CI 9.5 to 12.5). There was no statistically significant difference in hospital admissions between steroid and placebo groups. All reported adverse effects were minor.
Primary/Secondary Keywords